CASE NAME

Do No Harm v. Pfizer Inc.

Download Opinionarrow_circle_right

Overview

Plaintiff is challenging Defendant’s “Breakthrough Fellowship Program” reserved for applicants that increase the pipeline for Black, Latino, and Native Americans.

Details

The district court held that Plaintiff had failed to establish standing and dismissed its application for a preliminary injunction.

On March 6, 2024, the Court of Appeals upheld the district court’s dismissal of the case, finding that Plaintiff lacked standing because it failed to name at least one member harmed by Defendant’s alleged discrimination.

On January 10, 2025, a full panel of judges in the Second Circuit Court of Appeals overturned the earlier decision. The court held that the earlier court of appeals decision applied the wrong test for determining standing. The court sent the case back to the district court to assist Plaintiff's standing according to the proper test.

Court

Second Circuit Court of Appeals

Status

Filed January 04, 2023 | Settled

On January 31, 2025, the parties settled the lawsuit, noting that in 2023, Pfizer had opened the eligibility criteria to applicants regardless of whether they were Black, Latino, or Native American, and had now decided to no longer accept new classes of fellows.

Relevant Law

Section 1981State law

New York State and City Human Rights Laws